Teresa Bair - Jan 2, 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Legal Officer
Signature
Teresa Bair
Stock symbol
KURA
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/4/2024, 04:07 PM
Previous filing
Feb 21, 2023
Next filing
Jan 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Award $0 +46.3K +186.63% $0.00 71K Jan 2, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +92.5K $0.00 92.5K Jan 2, 2024 Common Stock 92.5K $15.36 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28.
F2 Includes 1,657 shares acquired on May 17, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.
F3 This option vests in 48 equal monthly installments commencing on the grant date.